Dr. Alice B. Gottlieb, MD

Dr. Gottlieb practices at Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health.

Dr. Gottlieb's NPI, 1275581407, was assigned on May 4, 2006. Dr. Gottlieb holds Massachusetts license 227191.

Dr. Gottlieb's primary practice is Parkland Memorial Hospital, at 5200 Harry Hines Blvd, Dallas, TX 75235 in Dallas County. The practice phone is (214) 590-8000.

Dr. Gottlieb's primary practice is Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health. Dr. Gottlieb is also affiliated with NYC Health + Hospitals/Metropolitan. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Gottlieb to 2 more medical groups, 1 clinical lab and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gottlieb practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Gottlieb's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Gottlieb is licensed in Massachusetts.

CMS data shows 375 Medicare services from Dr. Gottlieb across 7 procedure codes in 2024, for 155 Medicare patients. Medicare paid $20,891 for them. Every service was in an office.

CMS counts 155 Medicare patients who saw Dr. Gottlieb in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 58% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gottlieb's median patient age at 63, with 54% women.

In 2024, Dr. Gottlieb wrote 987 Medicare Part D claims for 195 patients. 51% of them were for generic drugs. CMS names the drug for 823 of them, across 25 drugs with 11 or more claims each, at $2,211,629 in total drug cost. In 2023, CMS named 413 claims across 14 drugs.

Dr. Gottlieb accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 137 papers to Dr. Gottlieb, published from 2018 to 2025. 2020 was the busiest year, with 20. The most frequent topics are Psoriasis, Antibodies, Monoclonal, Humanized and Arthritis, Psoriatic. Dr. Gottlieb has published most often in J Drugs Dermatol. Dr. Gottlieb's most frequent co-authors are Joseph F. Merola, MD, MMSC, Mark Gabriel Lebwohl and Philip J. Mease, MD.

Dmand AI links Dr. Gottlieb to 4 clinical trials. Conditions studied include Eczema, Dermatitis, Atopic and Psoriasis. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Gottlieb that name 4 trials.

CMS Open Payments shows 1,468 general payments to Dr. Gottlieb from 37 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Eli Lilly and Company paid the most, $373,703. It also lists 119 research payments totaling $301,398 from 2016 to 2023, naming 4 clinical trials.